Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-search-preview-high-loc· OpenAIHugging Face LMArena Search Arena 24K

Cisplatin treatment itself sometimes induces the activation of NF-κB in ovarian cancer…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Geminigemini-2.0-flash-grounding’s answer.
  1. User

    Cisplatin treatment itself sometimes induces the activation of NF-κB in ovarian cancer cells

  2. Assistant

    Cisplatin is a chemotherapy drug commonly used to treat ovarian cancer. Research indicates that cisplatin treatment can activate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in ovarian cancer cells. This activation may contribute to the development of resistance to cisplatin therapy. NF-κB is a transcription factor that regulates genes involved in cell survival, proliferation, and inflammation. When activated by cisplatin, NF-κB can promote the expression of anti-apoptotic genes, potentially reducing the effectiveness of the treatment. Understanding this mechanism is crucial for developing strategies to overcome cisplatin resistance in ovarian cancer therapy.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.